Concepedia

Erik H.F. Wong

EH

80

Publications

8.2K

Citations

40

H-Index

1975

Active since

Affiliations

Pfizer (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Institute of Organic Chemistry

AstraZeneca (United States)

NHS Lanarkshire

Erik H.F. Wong is an author at Pfizer (United States) specializing in medicine, neuropharmacology, and pharmacology.

Top concepts

Publications per year

1975–2016

80

Publications

80

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.

Erik H.F. Wong, J A Kemp, Tony Priestley et al. · Proceedings of the National Academy of Sciences · 1986 · 1.8K citations · Full text

, , +18

Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress

Georgia E. Hodes, Madeline L. Pfau, Marylène Leboeuf et al. · Proceedings of the National Academy of Sciences · 2014 · 684 citations · Full text

Non-competitive antagonists of excitatory amino acid receptors

John A. Kemp, Alan C. Foster, Erik H.F. Wong · Trends in Neurosciences · 1987 · 499 citations

, , +5

[<sup>3</sup>H]MK‐801 Labels a Site on the <i>N</i>‐Methyl‐D‐Aspartate Receptor Channel Complex in Rat Brain Membranes

Erik H.F. Wong, Antony R. Knight, Geoffrey N. Woodruff · Journal of Neurochemistry · 1988 · 456 citations

The novel anticonvulsant MK‐801 binds to the activated state of the N‐methyl‐<scp>d</scp>‐aspartate receptor in rat brain

Alan C. Foster, Erik H.F. Wong · British Journal of Pharmacology · 1987 · 450 citations · Full text

Rows per page

1–5 of 80